botanical extract DCB-BO1301
A proprietary botanical, galactolipid-enriched extract derived from the edible plant Crassocephalum crepidioides (Zhaohe Cao), with potential anti-inflammatory and antineoplastic activities. Upon oral administration, DCB-BO1301 may inhibit the growth of certain types of tumor cells, although the exact mechanism of action has yet to be fully elucidated.
| Synonym: | Zhaohe Cao-based botanical drug DCB-BO1301 |
|---|---|
| Code name: | DCB BO 1301 DCB BO1301 DCB-BO1301 |